Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,373	15,484	19,066	23,395	9,520	5,506
Short-Term Investments	580.75	652.72	6,164	6,512	13,612	10,544
Trading Asset Securities	1,081	3,057	5,560	2,296	5,616	3,466
Cash & Short-Term Investments	17,035	19,194	30,790	32,203	28,747	19,516
Cash Growth	-3.63%	-37.66%	-4.39%	12.02%	47.30%	-47.50%
Accounts Receivable	29,468	30,073	22,362	19,886	19,304	19,207
Other Receivables	605.03	50.12	46.58	110.46	74.88	151.41
Receivables	30,073	30,123	22,409	19,997	19,379	19,359
Inventory	36,617	32,798	26,779	27,437	19,759	18,918
Prepaid Expenses	-	7.05	7.97	7.25	5.78	7.23
Other Current Assets	4,906	3,212	3,570	2,479	964.07	184.17
Total Current Assets	88,631	85,334	83,555	82,123	68,855	57,984
Property, Plant & Equipment	62,789	63,152	66,740	49,726	31,641	26,661
Long-Term Investments	8,164	8,730	10,137	9,313	12,168	9,367
Other Intangible Assets	6,400	7,148	7,013	6,958	3,967	4,402
Long-Term Accounts Receivable	-	-	-0	0	0	0
Long-Term Deferred Tax Assets	6,140	6,140	4,365	4,071	3,741	2,834
Other Long-Term Assets	867.29	859.02	1,666	1,344	688.89	9,040
Total Assets	173,992	172,363	173,477	153,536	121,062	110,288
Accounts Payable	7,035	7,325	4,851	4,806	5,111	3,365
Accrued Expenses	9,154	10,699	11,868	12,407	10,038	342
Short-Term Debt	41,626	41,537	39,330	25,064	10,262	4,220
Current Portion of Long-Term Debt	2,667	1,932	-	2,000	191.4	3,216
Current Portion of Leases	179.3	250.58	152.42	151.35	82.2	41.57
Current Income Taxes Payable	103.37	-	-	883.22	840.4	982.53
Current Unearned Revenue	-	-	-	2.46	-	-
Other Current Liabilities	14,302	13,452	14,119	11,944	7,244	14,812
Total Current Liabilities	75,065	75,195	70,320	57,258	33,770	26,980
Long-Term Debt	6,278	6,592	6,746	3,746	2,000	2,191
Long-Term Leases	113.62	145.65	61.2	135.05	65.21	33.16
Other Long-Term Liabilities	11,688	10,140	7,275	3,851	3,370	3,270
Total Liabilities	94,393	92,684	84,402	64,990	39,933	32,721
Common Stock	7,664	7,664	7,664	7,664	7,664	4,911
Additional Paid-In Capital	40,473	40,143	40,143	40,143	40,143	42,919
Retained Earnings	35,439	35,520	43,743	43,156	35,904	31,983
Treasury Stock	-3,082	-3,082	-3,082	-3,082	-3,082	-2,536
Comprehensive Income & Other	-895.46	-565.06	608.09	665.54	501.14	290.23
Shareholders' Equity	79,599	79,679	89,075	88,546	81,129	77,566
Total Liabilities & Equity	173,992	172,363	173,477	153,536	121,062	110,288
Total Debt	50,863	50,457	46,289	31,096	12,601	9,702
Net Cash (Debt)	-33,828	-31,263	-15,499	1,107	16,146	9,814
Net Cash Growth	-	-	-	-93.14%	64.53%	-20.89%
Net Cash Per Share	-2254.32	-2082.32	-526.62	73.29	1071.03	650.58
Filing Date Shares Outstanding	15.01	15.01	15.01	15.01	15.01	14.36
Total Common Shares Outstanding	15.01	15.01	15.01	15.01	15.01	14.36
Working Capital	13,566	10,139	13,235	24,865	35,085	31,004
Book Value Per Share	5301.83	5307.22	5933.04	5897.81	5403.78	5400.05
Tangible Book Value	73,198	72,531	82,062	81,588	77,162	73,164
Tangible Book Value Per Share	4875.53	4831.12	5465.90	5434.34	5139.54	5093.59
Land	-	10,884	11,406	10,188	9,607	7,151
Buildings	-	25,046	30,181	12,824	15,655	14,011
Machinery	-	15,334	31,527	8,822	15,961	14,075
Construction In Progress	-	9,767	10,784	16,418	1,608	584.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.